HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shozo Tobimatsu Selected Research

Polyneuropathies (Polyneuropathy)

11/2020Optic, trigeminal, and facial neuropathy related to anti-neurofascin 155 antibody.
4/2007A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shozo Tobimatsu Research Topics

Disease

3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2012
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
11/2020 - 04/2007
2Polyneuropathies (Polyneuropathy)
11/2020 - 04/2007
2Demyelinating Diseases (Demyelinating Disease)
11/2020 - 04/2007
2Cognitive Dysfunction
01/2016 - 01/2012
2Wounds and Injuries (Trauma)
05/2011 - 04/2004
2Brain Death (Brain Dead)
03/2005 - 04/2004
2Myelitis
12/2004 - 09/2002
1Hypertrophy
11/2020
1Glaucoma
05/2011
1Ocular Hypertension (Glaucoma, Suspect)
05/2011
1Stress Urinary Incontinence
04/2011
1Urinary Incontinence
04/2011
1Neuromyelitis Optica (Devic's Disease)
06/2009
1Multiple Sclerosis
06/2009
1Parkinson Disease (Parkinson's Disease)
01/2009
1Retinal Degeneration
12/2008
1Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2008
1Cerebellar Ataxia (Dysmetria)
06/2007
1Diaschisis
06/2007
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2007
1Acquired Immunodeficiency Syndrome (AIDS)
04/2007
1Disease Susceptibility (Diathesis)
12/2004
1Myotonic Dystrophy (Dystrophia Myotonica)
03/2003
1Epilepsy (Aura)
09/2002
1Temporal Lobe Epilepsy
09/2002
1Peripheral Nervous System Diseases (PNS Diseases)
09/2002
1Multiple System Atrophy
08/2002
1Hypertension (High Blood Pressure)
05/2002
1Hemifacial Spasm
04/2002
1Epilepsia Partialis Continua
01/2002

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2012
2Immunoglobulin G (IgG)IBA
11/2020 - 06/2009
2pigment epithelium-derived factorIBA
05/2011 - 12/2008
2Glucose (Dextrose)FDA LinkGeneric
08/2002 - 05/2002
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2016
1Retinaldehyde (Retinal)IBA
05/2011
1DAPIIBA
05/2011
1N-Methylaspartate (NMDA)IBA
05/2011
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2008
1Neuroprotective AgentsIBA
12/2008
1sperm releasing substanceIBA
06/2007
11- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA
04/2007
1Inositol (Myoinositol)IBA
03/2005
1Mannitol (Osmitrol)FDA LinkGeneric
04/2004
1Protein Kinases (Protein Kinase)IBA
03/2003
1Immunoglobulin E (IgE)IBA
09/2002
1AntigensIBA
09/2002
1fluorodopa F 18IBA
08/2002
1SaltsIBA
05/2002
1Lysergic Acid Diethylamide (LSD)IBA
05/2002
1erucylphosphocholineIBA
01/2002

Therapy/Procedure

2Electrodes (Electrode)
01/2009 - 09/2002
2Immunotherapy
04/2007 - 12/2004
1Intravitreal Injections
05/2011
1Therapeutics
05/2011
1Prostatectomy (Retropubic Prostatectomy)
04/2011
1Deep Brain Stimulation
01/2009
1Transcranial Magnetic Stimulation
04/2007
1Sodium-Restricted Diet (Diet, Sodium Restricted)
05/2002
1Microvascular Decompression Surgery
04/2002